AU2705795A - Immune modulation with class ii alpha-chain fragments - Google Patents

Immune modulation with class ii alpha-chain fragments

Info

Publication number
AU2705795A
AU2705795A AU27057/95A AU2705795A AU2705795A AU 2705795 A AU2705795 A AU 2705795A AU 27057/95 A AU27057/95 A AU 27057/95A AU 2705795 A AU2705795 A AU 2705795A AU 2705795 A AU2705795 A AU 2705795A
Authority
AU
Australia
Prior art keywords
alpha
class
chain fragments
immune modulation
immune
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU27057/95A
Other languages
English (en)
Inventor
Carol Clayberger
Alan M. Krensky
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Leland Stanford Junior University
Original Assignee
Leland Stanford Junior University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leland Stanford Junior University filed Critical Leland Stanford Junior University
Publication of AU2705795A publication Critical patent/AU2705795A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70539—MHC-molecules, e.g. HLA-molecules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4738—Cell cycle regulated proteins, e.g. cyclin, CDC, INK-CCR
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU27057/95A 1994-06-16 1995-06-16 Immune modulation with class ii alpha-chain fragments Abandoned AU2705795A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US26054894A 1994-06-16 1994-06-16
PCT/US1995/007673 WO1995034321A1 (en) 1994-06-16 1995-06-16 Immune modulation with class ii alpha-chain fragments
US260548 2005-10-27

Publications (1)

Publication Number Publication Date
AU2705795A true AU2705795A (en) 1996-01-05

Family

ID=22989611

Family Applications (1)

Application Number Title Priority Date Filing Date
AU27057/95A Abandoned AU2705795A (en) 1994-06-16 1995-06-16 Immune modulation with class ii alpha-chain fragments

Country Status (5)

Country Link
EP (1) EP0723458A4 (ja)
JP (1) JPH09503003A (ja)
AU (1) AU2705795A (ja)
CA (1) CA2169762A1 (ja)
WO (1) WO1995034321A1 (ja)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6436903B1 (en) * 1996-05-22 2002-08-20 Stanford University (Board Of Trustees Of The Leland Standford Junior University) Immunomodulating compounds comprising d-isomers of amino acids
AU7298398A (en) * 1996-11-19 1998-06-10 Sangstat Medical Corporation Enhanced effects for hapten conjugated therapeutics
AU4454700A (en) * 1999-04-12 2000-11-14 Stanford University Interaction of mhc class ii proteins with members of the pcna family of proteins
KR100863632B1 (ko) 2000-03-31 2008-10-15 퍼듀 리서치 파운데이션 리간드-면역원 접합체를 사용한 치료 방법
GB0609121D0 (en) 2006-05-09 2006-06-21 Univ Birmingham Peptide Therapy

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0006916B1 (en) * 1977-09-28 1981-07-08 National Research Development Corporation Immunological preparations incorporating mhc antigens and their production
US5130295A (en) * 1989-01-05 1992-07-14 Consortium For Surface Processing Passivating thin film for superconducting material
US5364762A (en) * 1990-03-21 1994-11-15 Board Of Trustees Of The Leland Stanford Junior University Major histocompatibility complex (MHC) molecules
WO1994013320A1 (en) * 1992-12-17 1994-06-23 Subramaniam Sriram Vaccination with peptide of mhc class ii molecules for treatment of autoimmune disease

Also Published As

Publication number Publication date
WO1995034321A1 (en) 1995-12-21
CA2169762A1 (en) 1995-12-21
EP0723458A1 (en) 1996-07-31
EP0723458A4 (en) 1998-03-11
JPH09503003A (ja) 1997-03-25

Similar Documents

Publication Publication Date Title
AU2395895A (en) Melanoma antigens
AU3811495A (en) Antibodies
AU1326395A (en) Micropump
AU7101094A (en) Factor ix - polymeric conjugates
AU6029594A (en) Factor viii - polymeric conjugates
AU3160595A (en) Revolving-door drive
AU2882795A (en) Hob
AU4344696A (en) Oligonucleotide-dendrimer conjugates
AU4132097A (en) Immune direction therapy
AU3994095A (en) Thrombocytotic factor
AU2892995A (en) Authentication technique
AU2705795A (en) Immune modulation with class ii alpha-chain fragments
AU3943295A (en) Reflector
AU3877795A (en) Toxins from the wasp bracon hebetor
AU1726095A (en) Heat reactivatable adhesive
AU2053595A (en) Reflector
AU3712795A (en) Portable oven
AU653705B3 (en) The looking glass
AUPM447694A0 (en) Antigen composition
AUPN008794A0 (en) Solar oven
AUPM612694A0 (en) Reflector
AU661961B3 (en) Closure assembly
AU1786095A (en) Relative curve
AUPM738994A0 (en) The secure enhancing condom
AUPM519394A0 (en) Sun slopper